Placement of CC [Bioanalytics]

posted by Ohlbe – France, 2020-05-26 17:32 (355 d 05:16 ago) – Posting: # 21479
Views: 5,431

Dear Helmut,

» Many CROs have the CC in duplicates only at the start of the run. IMHO, that should be avoided. I prefer to have one set of singlets at the start and another at the end.

Really ? I usually see only singlets, not duplicates (in the past many labs analysed the LLOQ and ULOQ samples in duplicate, with only one of the results being used following an SOP, but all others were singlets). If duplicate samples are used, it is indeed rather strange to put both at the beginning.


Complete thread:

 Admin contact
21,462 posts in 4,487 threads, 1,514 registered users;
online 17 (0 registered, 17 guests [including 12 identified bots]).
Forum time: Sunday 22:48 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz